Independent associations of plasma GFAP with amyloid‐β and tau in Alzheimer’s disease
Wan Lu Jia(Montreal Neurological Institute and Hospital), Pedro Rosa‐Neto(Center for Diagnosis and Research on Alzheimer's Disease), Joseph Therriault(Douglas Mental Health University Institute), Nicholas J. Ashton(King's College London), Eduardo R. Zimmer(Universidade Federal do Rio Grande do Sul), Kaj Blennow(Sahlgrenska University Hospital), Jaime Fernández Arias(Douglas Mental Health University Institute), Nesrine Rahmouni(McGill University), Andréa Lessa Benedet(University of Pittsburgh), Arthur C. Macedo(Montreal Neurological Institute and Hospital), Thomas K. Karikari(University of Pittsburgh), Peter Kunach(Southwestern Medical Center), Stijn Servaes(Douglas Mental Health University Institute), Yi‐Ting Wang(McGill University), Firoza Z Lussier(McGill University), Cécile Tissot(Hirslanden Clinique des Grangettes), Serge Gauthier(Texas Instruments (France)), Henrik Zetterberg(University of Wisconsin System), Tharick A. Pascoal(Montreal Neurological Institute and Hospital)
Cited by 1
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k